How genetic testing is guiding the use of PARP inhibitors
8 May 2019
How genetic testing is guiding the use of PARP inhibitors
Translating implementation science
Conducting implementation science
Challenges to Jordanian Muslim men with prostate cancer
Supporting parents of children with incurable cancer
Using real world data to provide aftercare plans
Pharmacology update from ONS 2019
Managing the side effects of CAR T-cell therapy
Role of radiation therapy with immunotherapy: Nurse’s perspective
Updates in surgical oncology
Clinical photography in cancer care
How the WIN consortium achieves its goals